FIA
MAIA icon

FNY Investment Advisers’s MAIA Biotechnology MAIA Stock Holding History

FNY Investment Advisers’s Portfolio MAIA Stock Details MAIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-17,550
Closed -$38K – 646
2023
Q3 		$38K Buy
+17,550
New +$34.7K 0.02% 252

Other funds holding MAIA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CWM
Centric Wealth Management Chicago, Illinois $501M AUM 15.27% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
NW
Naviter Wealth Little Rock, Arkansas $801M AUM 22.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FNY Investment Advisers's MAIA Position: Q4 2023 in Review

FNY Investment Advisers sold out of MAIA Biotechnology (MAIA) in Q4 2023, closing a stake of 17,550 shares — an estimated $38K sold.

FNY Investment Advisers first reported a position in MAIA in Q3 2023 and held it in 1 quarter. The position peaked at $38K in Q3 2023. 22 funds tracked by Wall St. Rank hold MAIA as of Q4 2023.

  • FNY Investment Advisers reported no remaining MAIA Biotechnology position as of Q4 2023 after selling out during the quarter.
  • FNY Investment Advisers sold 17,550 MAIA Biotechnology shares in Q4 2023, an estimated $38K.
  • FNY Investment Advisers first reported a position in MAIA Biotechnology in Q3 2023 and held it in 1 quarter.
  • FNY Investment Advisers's MAIA Biotechnology position peaked at $38K in Q3 2023.
  • 22 funds tracked by Wall St. Rank held MAIA Biotechnology as of Q4 2023.

Based on FNY Investment Advisers's 13F filing for Q4 2023, filed 12 Jan 2024.